Newsroom

News

They are pathogens on contaminated food: Listeria bacteria can cause symptoms such as fever and diarrhoea, lead to premature births or miscarriages, or cause a deadly infection in people with a compromised immune system. Scientists at Technische Universität Braunschweig have found a new biomarker, a molecular feature, for the bacteria and generated new antibodies for the pathogens. The results could be used in diagnostics to further improve diagnostic procedures. The study involved the Helmholtz Centre for Infection Research (HZI), the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures and the Universities Federal do Agreste de Pernambuco and Federal de Pelotas, Brazil. The study was recently published in the journal Scientific Reports.

16.10.2020

HZI Campus

News

Mild or asymptomatic infections with the SARS coronavirus-2 are often not detected. Antibody studies can provide reliable information on what percentage of the population has already been infected with SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI) in Braunschweig is coordinating a nationwide study to determine the spread of antibodies against SARS-CoV-2. Population samples will be examined in ten selected regions until summer 2021. From 14 October, around 3000 test persons from the city and district of Osnabrück will be invited to take part in the antibody test.

14.10.2020

HZI Campus

News

In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the origins of the first SARS-CoV-2 outbreak in May 2020 at Tönnies in Rheda-Wiedenbrück, Germany's largest meat processing complex, were investigated. The study was published on the preprint platform SSRN in July 2020. The results have now been peer-reviewed and were published in the journal EMBO Molecular Medicine.

08.10.2020

HZI Campus

News

The Royal Swedish Academy of Sciences has awarded this year’s Nobel Prize in Chemistry to Emmanuelle Charpentier, former Head of the Department “Regulation in Infection Biology” at the Helmholtz Centre for Infection Research (HZI), Braunschweig, and Professor at the Hannover Medical School, Hannover, for her groundbreaking work on the CRISPR-Cas9 gene editing technology. She shares the prize with Jennifer A. Doudna.

07.10.2020

HZI Campus

News

Even though we have been living with the COVID- pandemic for more than half a year, there are still many unanswered questions and major uncertainties regarding further infection. How will the epidemic develop in Germany – especially during the upcoming flu season and the cold autumn and winter months? Which strategies are particularly effective in containing the rising number of infections in Germany and worldwide? What has proved successful in recent months? What properties of SARS-CoV- are now understood? And what measures can be imposed for the population and the economy without restricting social life too much?

24.09.2020

HZI Campus

News

Many SARS-coronavirus-2 infections are mild or completely asymptomatic and are therefore not detected. This makes it difficult to assess pandemic trends, prevention strategies and mortality rates. Antibody studies can provide reliable information on what percentage of the population has already been infected with SARS-CoV-2. In a nationwide study, the Helmholtz Centre for Infection Research (HZI) in Braunschweig is using regional samples to investigate the spread of antibodies against the novel coronavirus. The study examines about 3000 test persons in the urban region of Aachen from 9th September 2020.

09.09.2020

HZI Campus

Back to the first page
...
60
61
62
63
...
150

HZI in the media

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

19.12.2025

healthcare-in-europe.com

Biosyntheseweg aufzuklären. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit ...

18.12.2025

Bionity.COM

Finanzierungsmöglichkeiten fehlen.

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI)

16.12.2025

MedMedia

Korte from the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI).

The research was carried out as

12.12.2025

The Hindu

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

12.12.2025

Bionity.COM

Einrichtungen des regionalen Forschungsökosystems – darunter das Helmholtz-Zentrum für Infektionsforschung (HZI), das Deutsche Zentrum für

12.12.2025

EUROPE SAYS

Korte of the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI). The findings emerged from the

12.12.2025

The New Indian Express

Universität Würzburg. Seit 2018: Postdoc am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Entwicklung Bayes’scher ...

12.12.2025

BIOspektrum

Center Borstel - Leibniz Lung Center, the Helmholtz Institute for Pharmaceutical Research Saarland and other scientific institutions in

11.12.2025

Technology Networks

von Humboldt professor, head of department at the Helmholtz Centre for Infection Research, Braunschweig and full professor at the Hannover

10.12.2025

European Research Council

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.